Meeting Banner
Abstract #0511

Investigation of the Correlation of MRS Measurable 2-Hydroxyglutarate (2HG) Concentration and Tumor Progression in Brain Tumors Harboring IDH1/2 Mutations

Liya Wang1, 2, Juliya Kalinina3, Ruya Zhao2, Run Lin1, 2, Shaoxiong Wu4, Erwin Van Meir3, Hui Mao1, 2

1Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, United States; 2Center for Systems Imaging, Emory University, Atlanta, GA, United States; 3Department of Neurosurgery, Emory University, Atlanta, GA, United States; 4Department of Chemistry, Emory University, Atlanta, GA, United States

Earlier studies suggest the mutation in isocitrate dehydrogenase 1/2 (IDH1/2) is a prognostic marker of glioma patients. The mutant enzyme gains a novel activity of producing the oncometabolite, R(-)-2-hydroxyglutarate (2HG), which can be detected in vivo and ex vivo by magnetic resonance spectroscopy. However, the role of 2HG in tumor development and progression remains to be better understood. This study investigated the relationships of 2HG concentrations obtained from magnetic resonance spectroscopic analysis with tumor progression features obtained from clinical pathology and radiology exams to explore the potential of using 2HG levels with as a biomarker for predicting brain tumor prognosis and responses to the treatment.

Abstract PDF Presentation Video

Keywords

abnormal accumulated activity additional agent among antibody appreciable approximately attempted availability available better biopsy brain characteristics characterize clinical clinically comparing concentration concentrations confirmed considered contrast contribute core correlated correlation cortex cystic dang detected determined developed development diagnosed diagnosis drastically edema elevated enhanced enhancement enhancements enzyme establish evidence exam examples exams excess excluded expand features finding findings formation frontal furthermore gains general grade grades harboring in vivo include includes increasing index indicated individual initial injection investigate investigation involved irregular isolated lobe magic malignant manually markedly marker mass materials measurable measured metabolite multiplying mutant mutants mutation mutations nature neurosurgery novel observations outlined overall panel parsons pathogenesis pathology patient patients plus positive positively post predicting previous production prognostic progressed progression proliferation radiology recurred recurrence relationships reported reports revealed samples science sciences section selected sets significantly slice slices spectra spectroscopy strong studies suggesting support systems tailed taken tissue treatment tumor tumors types verification visible visualized volume years